• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Biological Sciences
  2. Vol 20 (2), 2020
  3. 100-102
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Biological Sciences

Year: 2020 | Volume: 20 | Issue: 2 | Page No.: 100-102
DOI: 10.3923/jbs.2020.100.102
crossmark

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Mini Review

Practical Measures to Prevent COVID-19: A Mini-Review

Mehmet Ozaslan Mehmet  Ozaslan's LiveDNA, Muhamad Safdar Muhamad  Safdar's LiveDNA, I. Halil Kilic I. Halil  Kilic's LiveDNA and Rozhgar A. Khailany

ABSTRACT


In view of the global COVID-19 pandemic, this study focuses on the most up-to-date epidemiology, transmission, clinical manifestations, effective management, prevention and maintaining social distancing worldwide. The current outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease was first reported from Wuhan, China, in December, 2019. Till now this pandemic had spread to 209 countries and territories around the world and 2 international conveyances with 1,455,519 confirmed cases, including 83,664 deaths, as of April 08, 2020, so the World Health Organization declared it as a Public Health Emergency of worldwide (https://www.worldometers.info/coronavirus/). The main clinical manifestations are included fever, coughing, sore throat, fatigue, headache, diarrhea, hemoptysis, trouble breathing, blue lips or face, persistent pain or pressure in the chest, confusion and excessive drowsiness. Preventive measures such as; masks, frequent hand washing, staying at home, avoid public contact and quarantines are being recommended for reducing the transmission. To date, no specific antiviral treatment is proven yet. The countries with a high risk of infection, they need proper awareness and management for good protection.
PDF Abstract XML References Citation
Copyright: © 2020. This is an open access article distributed under the terms of the creative commons attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

How to cite this article

Mehmet Ozaslan, Muhamad Safdar, I. Halil Kilic and Rozhgar A. Khailany, 2020. Practical Measures to Prevent COVID-19: A Mini-Review. Journal of Biological Sciences, 20: 100-102.

DOI: 10.3923/jbs.2020.100.102

URL: https://scialert.net/abstract/?doi=jbs.2020.100.102

INTRODUCTION


Coronavirus (COVID-19) is an enveloped RNA virus that is diversely found in humans and wildlife. A total of six species have been identified to cause disease in humans. This pandemic had spread to 209 countries and 1,455,519 are confirmed cases, which are including 83,664 deaths to date. It is about 3.4% worldwide. Similarly, Middle East respiratory syndrome coronavirus (MERS-CoV) had become a worldwide health concern. MERS-CoV originally reported in 20121. It has affected more than 2000 people in 27 countries and 4 sub-continents in the Middle East. While the epidemic of SARS, affected 26 countries and resulted in more than 8000 cases in 20031. Since then, a small number of cases have occurred as a result of laboratory accidents or possibly, through animal-to-human transmission (Guangdong, China)1.

Coronaviruses cause illness in people and it can circulate among mammals and birds. Rarely animal coronaviruses can spread to human and then the human can spread to other humans. SARS-CoV-2 was first identified in Wuhan city, Hubei province, China, in December, 2019. Since then, it has spread to 209 countries all over the world when WHO declaring it a pandemic. The case fatality rate is approximately 2.3% based on initial information2. It is spherical to pleomorphic enveloped particles. Its envelope is studded in glycoproteins associated with nucleoprotein. The virus enters into the host cell and its genome is translated and transcribed. The translation is usually done by airborne droplets to the nasal cavity. Virus divides into the epithelium cells and causes total inflammation.

To date, no specific antiviral treatment is proven effective, hence, infected people initially rely on symptomatic treatments that showed encouraging profile for blocking the new coronavirus in early clinical trials, but preventive measures are the best treatment at this stage. This review aimed to focus the epidemiology, infection transmission, clinical characteristics, prevention and management of the SARS-CoV-2, so that it can help readers to have the latest understanding and practical measures of COVID-19.

EPIDEMIOLOGY

On 31 December, 2019, the WHO was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan, China. On 12 January, 2020, it was announced that a novel coronavirus had been identified in samples obtained from these cases and that initial analysis of virus genetic sequences suggested that this was the cause of the outbreak. As of 8 April, 2020, more than 1,467,471 cases have been diagnosed globally, with over 85,382 fatalities (https://www.worldometers.info/coronavirus/).

TRANSMISSION

The main danger or source from human to human is direct contact or infectious respiratory droplets. According to the currently available evidence, transmission through smaller droplet nuclei (airborne transmission) that propagate through the air at distances longer than 1 m is limited to aerosol-generating procedures during clinical care of COVID-19 patients3,4.

CLINICAL SYMPTOMS

The clinical manifestations which are seen till now are fever, coughing, sore throat, fatigue, headache, diarrhea, trouble breathing, blue lips or face, persistent pain or pressure in the chest, confusion and excessive drowsiness has been observed in a few cases. SARS-CoV-2 infection is more common in aged people between 60-80 years. These people are at high risk of primary infection with death rates, people from 20-59 years are at high risk of secondary infection and people are at least risk at the age of less than 20 years. Additionally, people with the weak immune system are the most prone to COVID-195-7.

PREVENTIVE MEASURES

WHO continues to recommend that everyone performs hand hygiene frequently, follows respiratory etiquette recommendations and regularly cleans and disinfects surfaces. Furthermore, people should take personal preventive equipment like gloves, gowns, masks and tissues (for sneezing and cough). In the severe condition, respirator (N95) is used along with disposal gowns, surgical gloves, goggles or face shields and wearing an isolated dress6-8.

CONCLUSION


COVID-19 is a deadly fatal and is transmitted worldwide. It caused diseases in people on a large scale. People must have awareness about its signs and symptoms mainly in travelers. They must report to health care centers about the signs and symptoms if they observe. Thus, proper measures should be taken to avoid the spread of infection and treat properly. The health officials should establish awareness programs, implement effective preventive policies and better hygiene setup, which is necessary for the eradication of the COVID-19.

SIGNIFICANCE STATEMENT


COVID-19 is a new strain of corona virus that had previously not been identified in humans. It first emerged in Wuhan, China, in December, 2019 and has since been declared as; an outbreak by WHO. In children and young people, the disease is not fatal. Older people or patients who already have diseases such as diabetes or heart problems may be vulnerable to becoming severely ill because of this virus. This study will help the researchers and public to uncover the critical areas of this disease that were not known to them. Thus, a new theory on COVID-19 epidemiology and management may be arrived at.

ACKNOWLEDGMENTS


We highly appreciate many members of the frontline medical and nursing staff who demonstrated selfless and heroic devotion to duty in the face of this outbreak.

REFERENCES


  1. De Wit, E., N. van Doremalen, D. Falzarano and V.J. Munster, 2016. SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Microbiol., 14: 523-534.
    CrossRefDirect Link

  2. Wang, C. and X. Wang, 2020. Prevalence, nosocomial infection and psychological prevention of novel coronavirus infection. Chin. Gen. Pract. Nurs., 18: 2-3.

  3. Cascella, M., M. Rajnik, A. Cuomo, S. Dulebohn and R.D. Napoli, 2020. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls Publishing, Treasure Island, FL.

  4. Chen, N., M. Zhou, X. Dong, J. Qu and F. Gong et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395: 507-513.
    CrossRefPubMedDirect Link

  5. Munster, V.J., M. Koopmans, N. van Doremalen, D. van Riel and E. de Wit, 2020. A novel Coronavirus emerging in China-key questions for impact assessment. N. Engl. J. Med., 382: 692-694.
    CrossRefPubMedDirect Link

  6. Van Doremalen, N., T. Bushmaker, D.H. Morris, M.G. Holbrook and A. Gamble et al., 2020. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New Engl. J. Med., 382: 1564-1567.
    Direct Link

  7. Adhikari, S.P., S. Meng, Y.J. Wu, Y.P. Mao and R.X. Ye et al., 2020. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect. Dis. Poverty, Vol. 9, No. 1.
    CrossRefDirect Link

  8. Li, Q., X. Guan, P. Wu, X. Wang and L. Zhou et al., 2020. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med., 382: 1199-1207.
    CrossRefPubMedDirect Link

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved